Search
Gossamer Bio Inc
GOSSAdd to Watchlist
9.280USD
-0.030-0.32%
Close 10-12 16:00（ET）
4.54BMarket Cap
LossP/E TTM
Gossamer Bio Inc (GOSS) Stock Price Target & Forecast
Analyst Rating
Based on 8 analysts giving stock ratings to Gossamer Bio Inc in the past month.
Hold
1 Strong Buy
3 Buy
3 Hold
1 Sell
0 Strong Sell
Target Price
82.480USD+785.93%
GOSS Analyst Recommendation Trends
In the current month, GOSS has received 3 Buy Ratings, 3 Hold Ratings, and 1 Sell Ratings. GOSS average Analyst price target in the last month is 82.480.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
0
1
1
1
3
3
3
3
3
3
3
3
6
5
5
3
4
5
5
4
1
1
1
0
0
0
0
0
0
0
0
1
1
1
1
1
0
0
0
8
8
10
10
9
10
9
9
GOSS Analyst Rating for Peer Comparison
Updated: Oct 12, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
Tempus AI Inc
TEM
4
7
11
0
1
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
14
1
0
0
23
Biontech SE
BNTX
4
13
5
0
0
22
IQVIA Holdings Inc
IQV
8
11
3
0
0
22
Financial Forecasting
Based on analysts' estimates, GOSS EPS is projected to reach -3.786 in FY2026Q3, following reported EPS of 4.225 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-15.65
-13.22
-9.94
-3.79
-3.76
Actual
-0.20
-0.20
4.22
--
--
Surprise
+98.70%
+98.49%
+142.49%
--
--
FAQs
What is Gossamer Bio Inc's expected revenue for the next quarter?
Gossamer Bio Inc's expected revenue is 10.66M.
What is Gossamer Bio Inc's price target?
Analysts forecast that Gossamer Bio Inc's price target is USD 82.48, with the highest forecast at USD 120.00 and the lowest forecast at USD 22.40.
How have Gossamer Bio IncGOSS's recent earnings per share performed?
The market expectation was USD 4.22, while Gossamer Bio IncGOSS's earnings per share (EPS) for the previous quarter was USD -0.20. EPS for the next quarter is expected at USD -3.79.
What is the analyst rating for Gossamer Bio Inc?
Based on the ratings of Gossamer Bio Inc's stock from 8 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.